We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

44 hedge funds and large institutions have $212M invested in Cogent Biosciences in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 11

57% more funds holding

Funds holding: 28 → 44 (+16)

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

14% more capital invested

Capital invested by funds: $186M → $212M (+$26.7M)

9.35% less ownership

Funds ownership: 22.23% → 12.88% (-9.3%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
44
Holders Change
+16
Holders Change %
+57.14%
% of All Funds
1.01%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
28
Increased
5
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NLVP
New Leaf Venture Partners
New York
+$15M
2
CI
Cowen Inc
New York
+$6.98M
3
BlackRock
BlackRock
New York
+$5.36M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.87M
5
Bank of America
Bank of America
North Carolina
+$1.24M

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$3.16M
2
Victory Capital Management
Victory Capital Management
Texas
-$2.78M
3
Morgan Stanley
Morgan Stanley
New York
-$2.26M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.09M
5
MIM
Monashee Investment Management
Massachusetts
-$1.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
AVAI
1
Atlas Venture Associates IX
Massachusetts
$48.2M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$34.6M – – –
NLVP
3
New Leaf Venture Partners
New York
$25.8M +$15M +311,386 +226%
Fidelity International
4
Fidelity International
Bermuda
$16.3M – – –
SAM
5
Sectoral Asset Management
Quebec, Canada
$15.5M – – –
Jennison Associates
6
Jennison Associates
New York
$13.3M +$463K +9,638 +4%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$11.9M – – –
NHAS
8
Novo Holdings A/S
Denmark
$9.54M – – –
SM
9
Sabby Management
Florida
$8.34M -$3.16M -65,637 -31%
Vanguard Group
10
Vanguard Group
Pennsylvania
$7.6M +$1.87M +38,943 +42%
BlackRock
11
BlackRock
New York
$6.4M +$5.36M +111,560 New
WA
12
Wasatch Advisors
Utah
$3.84M +$163K +3,381 +5%
PIM
13
Platinum Investment Management
Australia
$3.23M – – –
Point72 Asset Management
14
Point72 Asset Management
Connecticut
$2.15M -$2.09M -43,475 -54%
Bank of America
15
Bank of America
North Carolina
$1.49M +$1.24M +25,875 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$771K +$646K +13,440 New
Northern Trust
17
Northern Trust
Illinois
$620K +$520K +10,808 New
Goldman Sachs
18
Goldman Sachs
New York
$454K -$266K -5,538 -41%
Morgan Stanley
19
Morgan Stanley
New York
$361K -$2.26M -46,959 -88%
State Street
20
State Street
Massachusetts
$331K +$278K +5,775 New
Wells Fargo
21
Wells Fargo
California
$231K +$194K +4,031 New
KeyBank National Association
22
KeyBank National Association
Ohio
$195K +$163K +3,400 New
SIM
23
Spark Investment Management
New York
$186K +$156K +3,250 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$177K +$148K +3,076 New
AllianceBernstein
25
AllianceBernstein
Tennessee
$151K +$126K +2,625 New
1
2 3

COGT Hedge Fund Activity: Q2 2018 in Review

44 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q2 2018, worth a combined $212M — up 14% from $186M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new COGT positions and 11 closed out — a net gain of 17 holders — while 5 added to existing stakes and 4 trimmed.

The largest buyer was New Leaf Venture Partners, adding an estimated $15M. The largest seller was Sabby Management, cutting an estimated $3.16M.

  • 44 institutional investors held Cogent Biosciences (COGT) as of Q2 2018, up from 28 in Q1 2018.
  • Funds reported $212M of Cogent Biosciences stock for Q2 2018, up 14% quarter-over-quarter.
  • 28 funds opened new Cogent Biosciences positions in Q2 2018 and 11 closed out, a net change of +17 holders.
  • The largest Cogent Biosciences buyer in Q2 2018 was New Leaf Venture Partners, an estimated $15M added.
  • The largest Cogent Biosciences seller in Q2 2018 was Sabby Management, an estimated $3.16M sold.

Based on aggregated 13F filings for Q2 2018.